Molina Healthcare Inc (MOH, Financial) is set to release its Q4 2024 earnings on Feb 5, 2025. The consensus estimate for Q4 2024 revenue is $10.32 billion, and the earnings are expected to come in at $5.53 per share. The full year 2024's revenue is expected to be $40.39 billion and the earnings are expected to be $21.89 per share. More detailed estimate data can be found on the Forecast page.
Revenue estimates for Molina Healthcare Inc (MOH) have declined from $40.42 billion to $40.39 billion for the full year 2024 and declined from $43.61 billion to $43.52 billion for 2025 over the past 90 days. Earnings estimates for Molina Healthcare Inc (MOH) have increased from $21.62 per share to $21.89 per share for the full year 2024 and increased from $24.67 per share to $24.74 per share for 2025 over the past 90 days.
In the previous quarter of 2024-09-30, Molina Healthcare Inc's (MOH) actual revenue was $10.34 billion, which beat analysts' revenue expectations of $9.91 billion by 4.33%. Molina Healthcare Inc's (MOH) actual earnings were $5.65 per share, which beat analysts' earnings expectations of $5.47 per share by 3.29%. After releasing the results, Molina Healthcare Inc (MOH) was up by 17.67% in one day.
Based on the one-year price targets offered by 15 analysts, the average target price for Molina Healthcare Inc (MOH) is $357.82 with a high estimate of $406 and a low estimate of $309. The average target implies an upside of 9.98% from the current price of $325.36.
Based on GuruFocus estimates, the estimated GF Value for Molina Healthcare Inc (MOH, Financial) in one year is $462.61, suggesting an upside of 42.18% from the current price of $325.36.
Based on the consensus recommendation from 17 brokerage firms, Molina Healthcare Inc's (MOH, Financial) average brokerage recommendation is currently 2.6, indicating a "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。